Skip to content

Clinical trials

Phase 2 Leishmaniasis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leishmaniasis Phase: Phase 2 Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20061
20071
20082
20092
20103
20111
20131
20141
20151
20181
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
U.S. Army Medical Research and Development Command5
Access to Advanced Health Institute (AAHI)2
Foundation Fader2
Fundacion Nacional de Dermatologia2
AB Foundation1
Brasilia University Hospital1
Centro de Investigaciones Bioclínicas de la Fundación Fader1
Hospital Universitário Professor Edgard Santos1
Knight Therapeutics (USA) Inc1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leishmaniasis20
Leishmaniasis, Cutaneous14
Leishmaniasis, Mucocutaneous4
Communicable Diseases1
Hypersensitivity, Delayed1
Immune System Diseases1
Rare Diseases1
Skin Diseases1

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.